GT Biopharma Inc.

08/12/2021

Don't forget to register for GT Biopharma's Second Quarter Financial Results & Business Update! Tomorrow August 13th at 8:30am EST (NASDAQ: GTBP)

https://trike.bio/3lWT8VE

07/03/2021

Sneak peek behind the scenes at Anthony Ritossa's Global Family Office Investment Summit in Monaco!

06/11/2021

June 28th we'll be added to the Russell 2000® Index. This milestone represents another step towards the long term growth of GTBP.

Read the full press release here: https://www.gtbiopharma.com/news-media/press-releases/detail/222/gt-biopharma-to-be-added-to-the-russell-2000-index

BEVERLY HILLS, Calif., June 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biolo...

05/19/2021

Don't worry! There is still time to register for our data review call today at 4:00pm ET. Dr. Miller will be reviewing new findings supporting TriKE™ Monotherapy

Click to Register:
https://trike.bio/3wnqbV5

03/11/2021

GT Biopharma is pioneering immunotherapy technology to cure cancer and infectious diseases using its Trike Platform technology.

In just one minute our CEO Anthony Cataldo reviews the core functionality of the TriKE and how this can change the future of oncology. (NASDAQ: GTBP)